Our study confirms that the regulatory potential of CD4+CD25highGITR− cells (the most represented among CD25high cells [36]) is weaker in SLE patients than in HCs and that CD4+CD25highGITR− cells, expressing low levels of Treg markers, are activated cells. This evidence concerns the gene CD4 and systemic lupus erythematosus.